lysophosphatidic acid has been researched along with Nasopharyngeal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dawson, CW; Ibrahim, MH; Khoo, AS; Lee, HM; Murray, PG; Paterson, IC; Rajadurai, P; Taylor, GS; Thavaraj, S; Tsao, SW; Velapasamy, S; Vrzalikova, K; Wei, W; Yap, LF | 1 |
1 other study(ies) available for lysophosphatidic acid and Nasopharyngeal Neoplasms
| Article | Year |
|---|---|
Down-regulation of LPA receptor 5 contributes to aberrant LPA signalling in EBV-associated nasopharyngeal carcinoma.
Topics: Adenocarcinoma; Carcinoma; Cell Line, Tumor; Cell Movement; Down-Regulation; Epstein-Barr Virus Infections; Gene Expression Regulation, Neoplastic; Herpesvirus 4, Human; Humans; Lysophospholipids; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphoric Diester Hydrolases; Receptors, Lysophosphatidic Acid; Signal Transduction; T-Lymphocytes, Cytotoxic; Viral Matrix Proteins | 2015 |